Stomach Cancer Trial, Recruiting NCT06490159 Sponsor: City of Hope Medical Center Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06490159
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with stomach cancer (specifically a type called adenocarcinoma) that cannot be removed by surgery or has come back after treatment.
  • People who are 20 years of age or older.
  • People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scale (scores 0–2 on the ECOG scale).
  • People who have given written agreement to participate after being fully informed about the study.
  • People whose stomach cancer got worse during, or who could not tolerate, a first round of chemotherapy that included specific types of drugs (fluorinated pyrimidines and a platinum-based drug such as cisplatin or oxaliplatin).
  • People who have at least one area of cancer that can be measured or monitored using a CT scan or MRI.

Who may not be able to join:

  • People whose life expectancy is estimated to be less than 3 months.
  • People with serious heart problems (such as chest pain, heart attack, or irregular heartbeat), or conditions such as diabetes, high blood pressure, or bleeding problems that are not well controlled.
  • People who have a history of serious allergic reactions or serious reactions to medications.
  • People who have a significant mental health condition that would prevent them from completing questionnaires.
  • People whose treating doctor considers participation in the study to be unsuitable for them for any reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Koichi Takiguchi, PhD, City of Hope Medical Center

Phone: 6262183452

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2018
Est. completion
18 June 2028

Where this trial is recruiting

🇯🇵 Japan

Primary endpoints

Incidence of peripheral neuropathy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov